rs35744605

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 8P and 9B. PVS1BP6BS1BS2

The NM_022168.4(IFIH1):​c.1879G>T​(p.Glu627*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,611,082 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0036 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0053 ( 26 hom. )

Consequence

IFIH1
NM_022168.4 stop_gained

Scores

3
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:9

Conservation

PhyloP100: 1.26

Publications

72 publications found
Variant links:
Genes affected
IFIH1 (HGNC:18873): (interferon induced with helicase C domain 1) IFIH1 encodes MDA5 which is an intracellular sensor of viral RNA that triggers the innate immune response. Sensing RNA length and secondary structure, MDA5 binds dsRNA oligonucleotides with a modified DExD/H-box helicase core and a C-terminal domain, thus leading to a proinflammatory response that includes interferons. It has been shown that Coronaviruses (CoVs) as well as various other virus families, are capable of evading the MDA5-dependent interferon response, thus impeding the activation of the innate immune response to infection. MDA5 has also been shown to play an important role in enhancing natural killer cell function in malaria infection. In addition to its protective role in antiviral responses, MDA5 has been implicated in autoimmune and autoinflammatory diseases such as type 1 diabetes, systemic lupus erythematosus, and Aicardi-Goutieres syndrome[provided by RefSeq, Jul 2020]
IFIH1 Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina
  • IFIH1-related type 1 interferonopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Singleton-Merten syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Aicardi-Goutieres syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Singleton-Merten dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 95
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 2-162277580-C-A is Benign according to our data. Variant chr2-162277580-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377048.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00358 (545/152260) while in subpopulation NFE AF = 0.00614 (418/68024). AF 95% confidence interval is 0.00566. There are 4 homozygotes in GnomAd4. There are 235 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022168.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
NM_022168.4
MANE Select
c.1879G>Tp.Glu627*
stop_gained
Exon 10 of 16NP_071451.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IFIH1
ENST00000649979.2
MANE Select
c.1879G>Tp.Glu627*
stop_gained
Exon 10 of 16ENSP00000497271.1Q9BYX4-1
IFIH1
ENST00000648433.1
c.1762G>Tp.Glu588*
stop_gained
Exon 9 of 15ENSP00000496816.1A0A3B3IRK8
IFIH1
ENST00000679938.1
c.1567G>Tp.Glu523*
stop_gained
Exon 9 of 15ENSP00000505518.1A0A7P0Z4A9

Frequencies

GnomAD3 genomes
AF:
0.00358
AC:
545
AN:
152142
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00295
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00614
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00318
AC:
797
AN:
250898
AF XY:
0.00318
show subpopulations
Gnomad AFR exome
AF:
0.000493
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00171
Gnomad NFE exome
AF:
0.00585
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00534
AC:
7792
AN:
1458822
Hom.:
26
Cov.:
30
AF XY:
0.00526
AC XY:
3821
AN XY:
725876
show subpopulations
African (AFR)
AF:
0.000748
AC:
25
AN:
33418
American (AMR)
AF:
0.00119
AC:
53
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26114
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39652
South Asian (SAS)
AF:
0.000592
AC:
51
AN:
86202
European-Finnish (FIN)
AF:
0.00216
AC:
115
AN:
53364
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5756
European-Non Finnish (NFE)
AF:
0.00656
AC:
7282
AN:
1109430
Other (OTH)
AF:
0.00425
AC:
256
AN:
60284
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
352
705
1057
1410
1762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00358
AC:
545
AN:
152260
Hom.:
4
Cov.:
32
AF XY:
0.00316
AC XY:
235
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41554
American (AMR)
AF:
0.00295
AC:
45
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.00188
AC:
20
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00614
AC:
418
AN:
68024
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
28
56
85
113
141
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00477
Hom.:
5
Bravo
AF:
0.00327
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00752
AC:
29
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00558
AC:
48
ExAC
AF:
0.00326
AC:
396
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00589
EpiControl
AF:
0.00427

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
2
Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1;C5676929:Immunodeficiency 95 (2)
-
-
1
Aicardi-Goutieres syndrome 7 (1)
-
-
1
Aicardi-Goutieres syndrome 7;C4225427:Singleton-Merten syndrome 1 (1)
-
-
1
IFIH1-related disorder (1)
-
1
-
IFIH1-related immunodeficiency (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Singleton-Merten syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.59
CADD
Pathogenic
36
DANN
Uncertain
1.0
Eigen
Pathogenic
0.68
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.83
D
PhyloP100
1.3
Vest4
0.77
GERP RS
2.9
Mutation Taster
=123/77
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35744605; hg19: chr2-163134090; API